Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

General Notices

Findings of Research Misconduct
(NOT-OD-20-165)
National Institutes of Health

Findings of Research Misconduct
(NOT-OD-20-166)
National Institutes of Health

Notice of Changes to Funding Opportunities

Notice of NHLBI Participation in PAR-18-901 "Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)"
(NOT-HL-20-807)
National Heart, Lung, and Blood Institute

Notice of NHLBI Participation in PAR-19-098 "Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)"
(NOT-HL-20-808)
National Heart, Lung, and Blood Institute

Notice of Change in Application Due Date for RFA-HL-21-013 "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)"
(NOT-HL-20-811)
National Heart, Lung, and Blood Institute

Funding Opportunities

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
(PAR-20-238)
National Institute on Drug Abuse
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): ?May 17, 2021, May 17, 2022, May 17, 2023